CompletedNot Applicable

Hemostatic Variables In Snakebite Study

India96 participantsStarted 2022-03-15

Plain-language summary

Background Novelty The global assays of coagulation, namely the viscoelastometric tests and clot waveform has never been studied in detail before in snakebite victims. The pathophysiology of VICC including specific factor deficiencies and serial trend in blood cell indices amongst various hematotoxic snakebite in the region is not known. No Indian study to date has systematically examined the changes in early laboratory tests results in envenomed and non envenomed snakebite victims.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All patients with history suggestive of snakebite presenting within 6 hours of snakebite AND
✓. All providing a written informed consent and/or assent

Exclusion criteria

✕. All patients of stings or bites other than snakes
✕. All patients who received antivenom or blood products at another institute
✕. All patients with known hematological malignancies, coagulation disorders, chronic liver or renal failure.
✕. All patients known to be on warfarin, heparin or any newer oral or injectable anticoagulants
✕. All withdrawing a consent later on, or withdrawing assent later on-

What they're measuring

To study the serial change in CT of snakebite victims

Timeframe: up to 30 days

To study the serial change in fibrinogen levels of snakebite victims

Timeframe: up to 30 days

To study the serial change in D dimer levels of snakebite victims

Timeframe: up to 30 days

Trial details

NCT IDNCT04520282

SponsorJubilee Mission Medical College and Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-31

View on ClinicalTrials.gov More Snake Bites trials